|Bid||40.80 x 15600|
|Ask||42.00 x 15300|
|Day's range||40.80 - 41.40|
|52-week range||35.40 - 65.72|
|Beta (5Y monthly)||0.48|
|PE ratio (TTM)||342.86|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Image source: The Motley Fool. Enanta Pharmaceuticals Inc (NASDAQ: ENTA)Q3 2020 Earnings CallAug 4, 2020, 4:30 p.m. ETContents: Prepared Remarks Questions and Answers Call Participants Prepared Remarks: OperatorGood afternoon, and welcome to Enanta Pharmaceuticals' Fiscal Third Quarter Conference Call.
Enanta Pharmaceuticals (ENTA) delivered earnings and revenue surprises of 2.74% and -37.56%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2020 with Webcast and Conference Call Today at 4:30 p.m.